Intraosseous infusion, also called bone marrow infusion, is a medical procedure that involves inserting a small needle or catheter into the marrow space of bones to provide vascular access for fluid administration or drug delivery. It offers a fast and safe approach to deliver medications or fluids into a patient's circulatory system when intravenous access is not feasible or has failed. The most common sites for intraosseous infusion are the sternum, knee, tibia and humerus.
Advantages of Intraosseous Infusion
One of the major advantages of intraosseous infusion is that it provides vascular access within minutes without much difficulty even for those with little or no medical training. This makes it ideal for emergency situations where rapid access to the circulatory system is required for critical care but traditional intravenous access cannot be obtained. Some other key advantages are:
- It has a 90% success rate compared to 60% with peripheral intravenous access in emergency scenarios. The bone marrow offers a highly vascular structure comparable to large veins allowing quick absorption and distribution of fluids and drugs.
- Intraosseous Infusion Devices needles penetrate between 2-3 cm into the marrow space which ensures fluids administered do not leak into soft tissues but drain directly into venous sinusoids and venous system.
- Infusion rates are similar to intravenous therapy with flow rates up to 125 ml/minute achievable for both crystalloids and colloids using pressure infusion devices like pumps or gravity with hang height.
- Can be used for a variety of emergency fluids, resuscitation drugs and antibiotics that are normally administered intravenously. This makes it very useful when IV access cannot be obtained in trauma situations, shock, cardiac arrest, severe dehydration etc.
- Less painful compared to peripheral intravenous cannulation. Also has less complications like infiltration or site swelling compared to IV catheters in low perfusion states.
Types of Intraosseous Infusion Devices
There are different types of intraosseous devices presently available:
- Battery-powered drills - Early devices required manual drilling into bone which was time-consuming and difficult to use in the field. Newer battery-powered drills enable single-operator use and faster insertion in under 30 seconds.
- Spring-loaded devices - These have an internal spring mechanism that propels the sharp tip into the bone marrow space rapidly with the push of a button. Examples are EZ-IO and BIG.
- Battery/manual hybrid devices - Combine advantages of powered drills and manual insertion. Examples are INtraosseous-EZ by Pyng Medical.
- Passive stylets - Non-powered stylets require twisting or hammering motion for placement. Examples are bone injection guns.
All modern devices are designed for single use and come pre-loaded with needles ranging from 15-18 gauge in diameter and 1.5-2.5 inches in length. Some have additional features like adjustable depth, fluid adapters and securement devices.
Regulations and Training for Use
Intraosseous infusion is now considered a standard method of vascular access by various emergency medicine and trauma organizations. It has been approved by the U.S. Food and Drug Administration and is regulated as a Class II medical device. Most emergency medical service providers in developed nations incorporate intraosseous access training into their advanced life support protocols.
Proper operator training involving cognitive instruction as well as manikin based hands-on practice is essential to learn effective and safe placement technique. The American Heart Association also provides educational resources and guidelines on intraosseous infusion as part of their Advanced Cardiovascular Life Support (ACLS) protocols. Overall it is an important emergency procedure that more medical professionals should be competent to perform when required, especially in pre-hospital settings.
Complications and Contraindications
Like all medical procedures, intraosseous infusion devices also carries some risks which operators must be aware of:
- Bone fracture - There is a small chance of cracking or fracturing the bone during needle insertion. This usually does not delay treatment or cause long term issues.
- Osteomyelitis - Rare risk of infection inside the bone marrow which may lead to osteomyelitis. Proper antisepsis and sterile technique can minimize this.
- Embolism - Fat embolism into circulation if intramedullary needle penetrates into venous sinusoids. However, risks are very low with modern devices inserted in recommended sites.
- Extravasation - Leakage of infusate into soft tissues if needle is accidentally displaced. Monitored infusion and securement reduces this risk.
Relative contraindications for intraosseous access include absence of sufficient bone marrow such as in newborns, suspected or known bone abnormalities, joint infections near the site and local site trauma or burns over insertion areas. However, it may still be considered in emergency settings if no other viable option for lifesaving intervention is available.
ntraosseous infusion devices has emerged as a fast, safe andeffective alternative to intravenous therapy in critically ill patients when vascular access is difficult or delayed. Modern automatic and powered intraosseous devices have made the procedure quicker and more user-friendly for pre-hospital emergency providers. With appropriate training, intraosseous access can bridge the gap between catastrophic situations and definitive care, greatly improving chances of survival. Wider adoption and competence in intraosseous techniques is thus encouraged across various medical disciplines.
Get more insights on: - Intraosseous Infusion Devices
For Enhanced Understanding, Dive into the Report in the Language that Connects with You:-
· French
· German
· Italian
· Russian
· Japanese
· Chinese
· Korean
About Author:
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.
(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)
Intraosseous infusion refers to a very easy-to-learn, effective, and quick skill that helps in providing rapid vascular access for patients needing medications and fluids under certain circumstances.
Future Market Insights delivers key insights on the global intraosseous infusion devices market in a new publication titled “Intraosseous Infusion Devices Market: Global Industry Analysis & Opportunity Assessment, 2016–2026”.
In terms of revenue, the global intraosseous infusion devices market is projected to register a CAGR of 7.2% during the 10-year forecast period 2016 – 2026.
The global intraosseous infusion devices market was valued at US$ 2,553.9 Mn in 2015 and is estimated to be valued at US$ 2,719.3 Mn by 2016 end, reflecting a Y-o-Y growth rate of 6.5%.Future Market Insights analysts believe that a growing need for immediate vascular access and a rising number of emergency cases are expected to boost the overall market growth of the global intraosseous infusion devices market.
Other factors powering global demand for intraosseous infusion devices are – expansion of the global medical devices industry and its advancements, the increasing prevalence of chronic diseases such as obesity and cardiac arrests, and the rising adoption of intraosseous devices in the military and emergency medical services.However, a high possibility of compartment syndrome due to gushing of fluids and drugs into soft tissues; limitations in the case of individuals with severe osteoporosis and hypovolemic conditions; and impediment of IO infusion devices after the arrival of vein viewer are factors likely to restrict market growth over the forecast period.For more insights into the Market, Request a Sample of this Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1569“A key trend defining the global intraosseous infusion devices market is that larger players are concentrating on partnering with other companies to manufacture their products, along with expanding their current inventory by partnering with local companies for warehousing support.
Intraosseous infusion devices manufacturers are also increasingly concentrating on branding and marketing along with increasing product penetration through their local distributors.-Analyst, Future Market InsightsSegmentation highlightsThe global intraosseous infusion devices market is segmented on the basis of Product Type (B.I.G (Bone Injection Gun), FAST1, EZ-IO, FAST Responder, Intraosseous Needles, Others); Technology (Manual, Automatic); End User (Emergency Medical Services, Hospitals, Ambulatory Surgical Centres, Cardiac Care Centres); and Route of Administration (Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus, Head of Humerus).By the end of 2016, the Fast Responder product type segment is estimated to account for 6% of the market share while the EZ-IO segment is estimated to account for 21.1% market shareThe Automatic technology segment is expected to register a significant CAGR of 8.1% over the forecast period complemented by a high incremental opportunity of US$ 1,452.9 Mn between 2016 and 2026The Head of Humerus route of administration segment is expected to register a CAGR of 7.8% with a high incremental opportunity of US$ 624.8 Mn over the forecast periodThe Hospitals end-user segment is estimated to account for 30.1% of the market share by the end of 2016 while the Emergency Medical Services segment is anticipated to hold 31.1% market share in 2016.For any Queries Linked with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-1569Regional projectionsThe global intraosseous infusion devices market is segmented into the seven key regions of North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan, and the Middle East & Africa.
Intraosseous or IVD implantation is the insertion of a silicone implant for the treatment of illnesses such as sickle cell anemia, hemophilia, and others.
These implants can also be utilized to replace other damaged limbs or sections of the body.
The first is known as Inguinal Cord Dilation, while the second is known as the Intra-oral Pierson Technique (IUP).
Second, because the process of producing and delivering these intraosseous infusion devices is highly automated and can be completed in less time, the production cost is reduced.Another factor that has contributed to the global popularity of Intraosseous Injection Devices is the simplicity with which these injection devices may be utilized.
The Intraosseous Injection Device lowers the danger of any type of adverse effect, and the technology used in their production assures perfect sterility and cleanliness.
As a result, this specific product has gained a lot of recognition and popularity all over the world.Another major element that has contributed to the popularity of intraosseous infusion devices is their ease of use and mobility.
